Hi RW,
Nice idea. Someone started a similar thread back in June 2000, and it never took off... somehow I think your timing may be better. <g>
Quite a few of my favourites/mistakes are trading fairly near to cash, but for now, one of tuck's - ACLA.
December 31,
2001 2000
Cash, cash equivalents, short-term
and long-term investments $137,451 $ 192,612
Restricted cash $ 34,625 $ 1,750
$172,076 $ 194,362
Total assets $183,182 $ 203,008
Stockholders' equity $150,467 $ 164,555
SOURCE: ACLARA BioSciences, Inc.
Even allowing for the restricted cash (thanks to defeat in CALP litigation, if I remember), the cap is quite a bit lower.
Maybe not a 100% genuine 'biotech', though? Ferocious burn, too (though that's hardly unusual).
nig |
